The Company announced the development of the first antiviral to combat BK virus, one of the most common viral infections in transplant patients CANTON, Mass.--(BUSINESS WIRE)--Orthogon Therapeutics ...
When Tim Tavender developed a common virus, he had no idea it was the start of what would later become a cancer diagnosis. The 51-year-old from Southampton became ill with BK virus, also known as ...
Orthogon’s small molecule therapeutics redefine treatment possibilities for BK virus infections. CANTON, Mass.–(BUSINESS WIRE)–December 10, 2024– Orthogon Therapeutics, a developer of novel antiviral ...
Scientists think a very common childhood infection may be linked to bladder cancer — and now, they're figuring out the chain reaction that connects the two diseases. It's known that people who get ...
A virus that 95% of adults carry from childhood infections may be initiating bladder cancer decades later, according to research from the University of York and collaborating institutions. BK ...
Presenter: Jonathan Barratt, Ph.D., FRCP, The Mayer Professor of Renal Medicine, University of Leicester, U.K. About MAU868 MAU868, a first-in-class monoclonal antibody, has the potential to ...
Single-cell analysis helps uncover how the BK virus replicates, opening the door to new drug targets. BK polyomavirus (BKPyV) is a major cause of kidney transplant failure. Without a complete ...
Tackling a common childhood virus could open the door to preventing bladder cancer, according to new research funded by Kidney Research UK and York Against Cancer. The study, published in Science ...
CANTON, Mass.--(BUSINESS WIRE)--Orthogon Therapeutics, a developer of novel antiviral medicines, today announced the closing of an oversubscribed financing round, exceeding its $5M target and bringing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results